279.00MMarket Cap
14.99P/E TTM
Niagen Bioscience Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Niagen Bioscience Inc is 8.77, ranking 86 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is 14.99, which is 318.47% below the recent high of 62.72 and 65.44% above the recent low of 5.18.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.